Spectrum Brands Holdings, Inc. (SPB) is now among the bigger bargains in its industry.
Within the last year the price ranged from $45.05 – 66.5 and there is a wide opportunity to get in. Its next earnings report will be released on Jan 30, 2020.

Akebia Therapeutics, Inc.(AKBA)

move, based on 4 analysts offering 12 month price targets for Akebia Therapeutics in the last 3 months. The average price target is $15.50 with a high forecast of $16.00 and a low forecast of $15.00. The average price target represents a 124.64% increase from the last price of $6.90.

Analysts like Difei Yang from Mizuho Securities believe that we could see stock price minimum $16.00.

Another prominent analyst, Ed Arce of H.C. Wainwright rates AKBA as a Buy. The rating was made just 2 months ago.

Akebia Therapeutics, Inc.(AKBA) Recent News Reports

On average 0.0 articles are written each week about AKBA but this week 0 articles were written and they were 68% Bullish and 32% Bearish.

Akebia Therapeutics, Inc. Target Levels

The market experts are predicting that AKBA is a Strong Buy. Some other stocks to consider in this sector are:

CENT
ENR
PCRFY